Nykode Therapeutics ASA Total Liabilities

Latest as of June 2026: Nkr5.73 Million NOK ≈ $602.86K USD

Nykode Therapeutics ASA total liabilities. Based on the latest financial reports, Nykode Therapeutics ASA (NYKD) has total liabilities worth Nkr5.73 Million NOK (≈ $602.86K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nykode Therapeutics ASA (NYKD) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nykode Therapeutics ASA (2016–2025)

Total liabilities of Nykode Therapeutics ASA from 2016 to 2025. This chart illustrates how Nykode Therapeutics ASA's total liabilities have evolved over time, based on quarterly financial data.

Nykode Therapeutics ASA Competitors by Total Liabilities

The table below lists competitors of Nykode Therapeutics ASA ranked by their total liabilities.

Company	Country	Total Liabilities
Yg Plus Inc KO:037270	Korea	₩103.63 Billion
Freelance.Com PA:ALFRE	France	€364.30 Million
Arrow Exploration Corp V:AXL	Canada	CA$52.58 Million
Batulicin Nusantara Maritim Tbk PT JK:BESS	Indonesia	Rp56.29 Billion
Archimedes Tech SPAC Partners II Co. Ordinary Shares NASDAQ:ATII	USA	$8.18 Million
T.K.S. Technologies Public Company Limited BK:TKS	Thailand	฿1.04 Billion
RTX A/S CO:RTX	Denmark	Dkr181.37 Million
Thai Sugar Terminal Public Company Limited BK:TSTE	Thailand	฿2.12 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Nykode Therapeutics ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NYKD asset base.

Liquidity & Leverage Metrics

Nykode Therapeutics ASA Total Liabilities Ratios Explained

Nykode Therapeutics ASA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	11.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nykode Therapeutics ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nykode Therapeutics ASA (2016–2025)

The table below shows the annual total liabilities of Nykode Therapeutics ASA from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	Nkr8.42 Million ≈ $885.82K	-51.25%
2024-12-31	Nkr17.27 Million ≈ $1.82 Million	-53.24%
2023-12-31	Nkr36.93 Million ≈ $3.89 Million	-42.71%
2022-12-31	Nkr64.46 Million ≈ $6.78 Million	-9.85%
2021-12-31	Nkr71.50 Million ≈ $7.52 Million	+39.71%
2020-12-31	Nkr51.18 Million ≈ $5.39 Million	+1.30%
2019-12-31	Nkr50.52 Million ≈ $5.32 Million	+280.83%
2018-12-31	Nkr13.27 Million ≈ $1.40 Million	+21.29%
2017-12-31	Nkr10.94 Million ≈ $1.15 Million	+528.02%
2016-12-31	Nkr1.74 Million ≈ $183.26K	--

About Nykode Therapeutics ASA

OL:NYKD Norway Biotechnology

Market Cap

$121.96 Million

Nkr1.16 Billion NOK

Market Cap Rank

#18236 Global

#157 in Norway

Share Price

Nkr2.96

Change (1 day)

-3.74%

52-Week Range

Nkr2.12 - Nkr4.99

All Time High

Nkr91.25